Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-02-13Clinical Trial Update: Individualized Therapy Based of Tumoral mRNA Levels of ERCC1, RRM1 and BRCA1 in Advanced Non-Small-Cell Lung Cancer [Phase 2]
A Phase 2 trial assessed biomarker-guided therapy in advanced non-small cell lung cancer using tumor mRNA levels of ERCC1, RRM1, and BRCA1. …
-
CLINICAL_TRIALS trial_result · 2013-02-12Clinical Trial Update: Combination of RAD001 With Carboplatin, Paclitaxel and Bevacizumab in Non-small-cell Lung Cancer (NSCLC) Patients [Phase 1]
Phase 1 trial evaluating RAD001 (everolimus) in combination with carboplatin, paclitaxel, and bevacizumab in non-small cell lung cancer has …
-
CLINICAL_TRIALS trial_result · 2013-02-12Clinical Trial Update: Arsenic Trioxide in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer [Phase 2]
This update reports the completion of a phase 2 trial evaluating arsenic trioxide for locally advanced or metastatic non-small cell lung can…
-
CLINICAL_TRIALS trial_result · 2013-02-11Clinical Trial Update: Bryostatin 1 Plus Paclitaxel in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-small Cell Lung Cancer [Phase 2]
Phase 2 study evaluating Bryostatin 1 in combination with Paclitaxel for stage IIIB, stage IV, or recurrent non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2013-02-11Clinical Trial Update: Paclitaxel and Oxaliplatin in Treating Patients With Recurrent or Advanced Non-small Cell Lung Cancer [Phase 2]
A Phase 2 clinical trial evaluating the combination of paclitaxel and oxaliplatin in patients with recurrent or advanced non-small cell lung…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-02-11Clinical Trial Update: Bevacizumab, Paclitaxel, and Carboplatin Before Surgery in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluated neoadjuvant therapy with bevacizumab, paclitaxel, and carboplatin before surgery in patients with resectable non-s…
-
CLINICAL_TRIALS trial_result · 2013-02-11Clinical Trial Update: Radiation Therapy Plus Topotecan in Treating Patients With Non-small Cell Lung Cancer [Phase 1]
A Phase 1 clinical trial evaluated combining radiation therapy with topotecan in patients with non-small cell lung cancer, and the study sta…
-
CLINICAL_TRIALS trial_result · 2013-02-06Clinical Trial Update: A Phase II Study of Velcade® in Patients Stage IIIB OR IV Non-Small Cell Lung Cancer [Phase 2]
This entry reports a Phase II trial of Velcade (bortezomib) in patients with Stage IIIB or IV non-small cell lung cancer, which has been ter…
-
CLINICAL_TRIALS trial_result · 2013-02-05Clinical Trial Update: Induction Chemotherapy Using Paclitaxel, Carboplatin, CPT-11 With Pegfilgrastim [Phase 2]
This is a Phase 2 induction chemotherapy trial for non-small cell lung cancer using paclitaxel, carboplatin, irinotecan (CPT-11) with pegfil…
-
CLINICAL_TRIALS trial_result · 2013-02-04Clinical Trial Update: Gemcitabine Plus Carboplatin or Cisplatin in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial evaluating gemcitabine plus either carboplatin or cisplatin in patients with stage IIIB/IV or recurrent non-small cel…
-
CLINICAL_TRIALS trial_result · 2013-02-04Clinical Trial Update: Prediction of the Effectiveness of Hypofractionated Radiation Therapy in Early Stage Lung Cancer by Bio-imaging and Biomarkers [Phase 2]
Phase 2 trial evaluating the predictive value of bio-imaging and biomarkers for hypofractionated radiation therapy in inoperable early-stage…
-
CLINICAL_TRIALS trial_result · 2013-02-01Clinical Trial Update: Erlotinib and Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Inoperable Stage III Non-Small Cell Lung Cancer [Phase 1]
Phase 1 trial evaluating erlotinib with radiation therapy and chemotherapy for inoperable Stage III non-small cell lung cancer was terminate…
-
CLINICAL_TRIALS trial_result · 2013-01-31Clinical Trial Update: A Phase 1/2 Study Evaluating ABT-751 in Combination With Alimta in Advanced Non-Small Cell Lung Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating ABT-751 in combination with Alimta for advanced non-small cell lung cancer has completed the study.
-
CLINICAL_TRIALS trial_result · 2013-01-31Clinical Trial Update: S9900: Surgery With or Without Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer [Phase 3]
This Phase 3 study assessed surgery with or without combination chemotherapy in patients with non-small cell lung cancer; the trial has comp…
-
CLINICAL_TRIALS trial_result · 2013-01-31Clinical Trial Update: Oxaliplatin and Docetaxel as First-line Therapy for Advanced Non-small Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluating oxaliplatin plus docetaxel as first-line treatment for advanced non-small cell lung cancer was terminated, with r…
-
CLINICAL_TRIALS trial_result · 2013-01-30Clinical Trial Update: Randomised Study Comparing Three Chemotherapy Regimens in Non-small Cell Lung Cancer [Phase 3]
A Phase 3 randomized trial comparing three chemotherapy regimens in non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-01-30Clinical Trial Update: Regimen for the Treatment of Cachexia in Subjects With NSCLC [Phase 2]
Phase 2 clinical trial evaluating a regimen for treating cachexia in subjects with non-small cell lung cancer; results were posted in 2013 a…
-
CLINICAL_TRIALS trial_result · 2013-01-29Clinical Trial Update: Phase II Trial of Erlotinib and Concurrent Palliative Thoracic Radiation Therapy for Non-small Cell Lung Cancer (PEARL) [Phase 2]
Clinical trial PEARL is a Phase II study evaluating erlotinib with concurrent palliative thoracic radiation therapy for non-small cell lung …
-
CLINICAL_TRIALS trial_result · 2013-01-29Clinical Trial Update: First Line Gefitinib by FDG-PET Metabolic Response [Phase 2]
This clinical trial update describes a Phase 2 study evaluating first-line gefitinib in non-small cell lung cancer guided by FDG-PET metabol…
-
CLINICAL_TRIALS trial_result · 2013-01-29Clinical Trial Update: Paclitaxel/Carboplatin (PC) Followed by Gefitinib Versus PC in Advanced Non-small Cell Lung Cancer [Phase 2]
A Phase 2 randomized trial in advanced non-small cell lung cancer compares paclitaxel/carboplatin followed by gefitinib versus paclitaxel/ca…
-
CLINICAL_TRIALS trial_result · 2013-01-29Clinical Trial Update: Study of M2ES With Paclitaxel/Carboplatin (TC Regimen) in Advanced Non Small Cell Lung Cancer (NSCLC) [NA]
This entry reports the completion of a clinical trial evaluating M2ES with paclitaxel and carboplatin (the TC regimen) for advanced non-smal…
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: Study to Evaluate SID 530 Compared to Taxotere [Phase 3]
Phase 3 study evaluating SID 530 versus Taxotere in non-small cell lung cancer has completed. The trial evaluated efficacy and safety outcom…
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: GTI-2040 and Docetaxel in Treating Patients With Recurrent, Metastatic, or Unresectable Locally Advanced Non-Small Cell Lung Cancer, Prostate Cancer, or Other Solid Tumors [Phase 1, Phase 2]
Phase 1/2 trial evaluating GTI-2040 with docetaxel in patients with recurrent/metastatic non-small cell lung cancer or prostate cancer; the …
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: Bortezomib Plus Gemcitabine and Carboplatin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer [Phase 1]
This Phase 1 study assessed the safety and preliminary activity of combining bortezomib with gemcitabine and carboplatin in patients with ad…
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: Combination Chemotherapy Plus Radiation Therapy With or Without AE-941 in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed By Surgery [Phase 3]
A Phase 3 trial evaluating whether adding AE-941 to combination chemotherapy and radiation improves outcomes for patients with stage III non…